Pluripotency marker qPCR analysis is a cornerstone of iPSC quality control, detecting validated markers like LIN28A, OCT4, and SOX2 to verify undifferentiated states and ensure clinical safety, as cited in top journals. Creative Biolabs delivers high-confidence stemness profiles via high-throughput screening and ddPCR absolute quantification, providing standardized data to avoid phenotypic drift and meet rigorous standards for regenerative medicine research and applications.
Discover How We Can Help - Request a Consultation
Pluripotency Marker qPCR Analysis is a sensitive, quantitative molecular assay used to evaluate the pluripotent state of induced pluripotent stem cells (iPSCs) by detecting and quantifying the expression levels of core pluripotency-associated genes.
Quantitative real-time polymerase chain reaction (qPCR) relies on fluorescent signal amplification that is synchronized with DNA amplification cycles. By designing specific primers targeting core pluripotency genes, the assay quantifies the relative or absolute expression levels of these genes in iPSC samples. The results reflect the extent to which iPSCs maintain their undifferentiated, pluripotent identity.
The primary detected pluripotency markers are evolutionarily conserved core transcription factors that regulate the pluripotent network of stem cells, including:
Our workflow is designed to be a seamless extension of your laboratory, transforming raw biological samples into actionable regulatory-grade data through a rigorous five-step process.
As an industry leader in molecular characterization, Creative Biolabs provides a suite of customized solutions for Pluripotency Marker Analysis Service via qPCR tailored to the specific needs of biology experts and clinical researchers.
Optimization of codon-specific or isoform-specific targets to facilitate precise expression mapping in complex stem cell lineages.
Flexible processing from pilot-scale validation to large-scale industrial characterization of master cell banks.
Deployment of Droplet Digital PCR for ultra-sensitive detection of residual PSCs, ensuring the stability and safety of your cell therapy products.
Adherence to Quality-by-Design (QbD) principles and Process Analytical Techniques (PAT) to guarantee reproducible results across multiple batches.
Full transparency and assessment of procedures, providing the high-standard quality control tools necessary for IND/CMC regulatory filings.
Ability to run analysis in batch or longitudinal modes to track pluripotency markers throughout the entire differentiation or reprogramming timeframe.
Implementation of strict aseptic verification and rigorous quality assurance to evaluate the integrity of every biological sample.
Experience the Creative Biolabs Advantage - Get a Quote Today
A: While standard qPCR measures relative expression, ddPCR provides absolute quantification without a standard curve. This is crucial for detecting rare "leaky" expression or residual pluripotent cells in a differentiated population at sensitivities as low as 0.001%.
A: Based on recent international multisite studies, ESRG, LINC00678, and LIN28A are highly sensitive and robust. We typically recommend a multi-marker panel to ensure coverage across different cell lineages.
A: We generally require 500 ng to 1 μg of total RNA for a complete pluripotency panel, though our high-sensitivity protocols can accommodate lower concentrations if necessary. Please inquire for specific low-input requirements.
A: Yes, our procedures are designed with regulatory compliance in mind, utilizing validated primers and standardized reporting formats that align with international multisite evaluation standards for cell therapy products.
Creative Biolabs is dedicated to providing the precision analytics required for the next generation of regenerative medicine. Whether you are in the discovery phase or moving toward clinical trials, our team of specialists is ready to assist with your Pluripotency Marker Analysis Service via qPCR needs.
Contact Our Team for More Information and to Discuss Your Project
For Research Use Only. Not For Clinical Use.
